Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Infectious Disease
•
Tuberculosis
•
Pulmonology
•
Pulmonary Infections
Do you routinely monitor imaging or pulmonary function in patients with pulmonary TB after the completion of therapy?
Answer from: at Community Practice
The simple answer will be: NO.
Sign in or Register to read more
17975
Related Questions
What is the interpretation of two IGRAs with negative mitogen wells, in the absence of immunosuppression?
Does your institution have formal policies or work flows to reduce unnecessary IGRAs ordered for patients on biologics?
How would you approach treatment of latent TB for patients who cannot tolerate rifamycins or isoniazid due to allergy, intolerance, or drug-drug interactions?
Are there clinical scenarios in which you would start empiric treatment for pulmonary TB without microbiologic confirmation?
Have you used Karius to aid in the diagnosis of a non-resolving pneumonia, with negative bronchoscopy, biopsy, and other infectious work up in an immunocompetent patient?
Do you administer prophylactic antibiotics to prevent VAP following intubation in patients with acute brain injury?
Would you use the pneumococcal conjugate-21 vaccine (Capvaxive) instead of the conjugate-20 (Prevnar-20) for routine vaccinations in immunosuppressed patients?
Is there a role for chronic suppressive oral or inhaled therapy for recurrent Burkholderia cepacia pneumonia causing frequent hospitalizations in a patient with severe bronchiectasis with or without underlying cystic fibrosis?
What is your approach to duration of antibiotic therapy for treatment of a bacterial lung abscess?
What is your approach to prescribing RIPE for 6 month vs rifapentine/moxifloxacin for 4 months in the treatment of drug sensitive TB in the US?